Quality Matters

FEBRUARY 6, 2025

As more monoclonal antibody (mAb) therapies are developed (1 in 3 new drugs are monoclonal antibodies1) and as patent exclusivity expires, these treatments are becoming more widely available. Antigens are usually structures on the outside of the disease-causing agent. Anything that triggers an immune response is called an antigen.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunity Immunization Biosimilars 52

Putting Patients First Blog

NOVEMBER 12, 2024

Recognizing PrEP as a preventive service rather than as indicative of an active medical condition, as HHS proposes, could help address the current risk selection seen in the market. Clear guidance on the treatment of rebates within the ACF will help avoid distortions in pricing and prevent patients from bearing disproportionate costs.

Insurance Coverage and Processing 52

Insurance Coverage and Processing HIV Treatment and Prevention Agents Communication Hospitals 52

ID Stewardship

DECEMBER 11, 2024

I wonder if this will cause us to be more fragmented as a group in 2025 and if Bluesky will really have sticking power. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women | NEJM PURPOSE 1 RCT : No participants receiving twice-yearly lenacapavir acquired HIV infection. Mastodon sure did not.

HIV Treatment and Prevention Agents 145

HIV Treatment and Prevention Agents Labelling Hospitals Communication 145